{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:39:16Z","timestamp":1760315956947,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.eplepsyres.2012.01.009","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T18:48:15Z","timestamp":1328208495000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico)"],"prefix":"10.1016","volume":"100","author":[{"given":"Leopoldo","family":"Rivera-Casta\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Leal-Cantu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marita","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Davila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0959-4388(03)00066-7","article-title":"Auxiliary subunits: essential components of the voltage-gated calcium channel complex","volume":"13","author":"Arikkath","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2012.01.009_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","article-title":"Pregabalin pharmacology and its relevance to clinical practice","volume":"45","author":"Ben-Menachem","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1528-1167.2005.19204.x","article-title":"Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5664\/jcsm.26911","article-title":"Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy","volume":"3","author":"de Haas","year":"2007","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0035","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.0013-9580.2004.46703.x","article-title":"Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life","volume":"45","author":"de Weerd","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel \u03b12\u03b4 ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1528-1167.2005.00341.x","article-title":"Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(01)00216-9","article-title":"Proof of efficacy trials: endpoints","volume":"45","author":"French","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0055","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0060","unstructured":"Guy, W., 1976. Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology \u2013 Revised (DHEW Pub no. ADM 76-338). U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0065","series-title":"Measuring Functioning and Well Being","first-page":"235","article-title":"Sleep measures","author":"Hays","year":"1992"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the International League Against Epilepsy","volume":"22","author":"International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0075","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0080","first-page":"CD005612","article-title":"Pregabalin add-on for drug-resistant partial epilepsy","author":"Lozsadi","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1468-1331.2009.02916.x","article-title":"Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS)","volume":"17","author":"Ryvlin","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0090","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2147\/NDT.S4716","article-title":"Pregabalin for the management of partial epilepsy","volume":"4","author":"Ryvlin","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel \u03b12-\u03b4 (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0100","unstructured":"World Health Organization, 2009. Fact Sheet No 999: Epilepsy. http:\/\/www.who.int\/mediacentre\/factsheets\/fs999\/en\/index.html (accessed 01.07.11)."},{"key":"10.1016\/j.eplepsyres.2012.01.009_bib0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:27:59Z","timestamp":1760275679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0920121112000101"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.009","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico)","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}